Sangamo Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
[Day one] of the Bank of America Healthcare Conference. I'm Greg Harrison, one of the biotech analysts here at BofA. And today, we're lucky to have Sangamo Therapeutics with Sandy Macrae, Chief Executive Officer. Thank you for joining us.
Let's move right into Q&A.
Please.
Questions & Answers
The Fabry program and the ongoing Phase I/II STAAR study, for those new to the story, maybe you could review the current status of the program, and how your treatment could be differentiated compared to standard of care?
Well, we're really excited about the Fabry program. We're best-in-class, first-in-class, and now only in-class as the other gene therapies have all
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
